Your Mid-Year TRT Lab Review: Tracking Trends Over Time

Here's a question I ask men more often than you'd think: do you remember what your testosterone number was six months ago? Most can rattle off the one from their last visit. Almost nobody remembers the one before that. And that's the whole problem with how we tend to think about lab work. We treat each blood draw like a snapshot, a single grade on a single test, when the real story lives in the line connecting all those dots over time.

I'm Dr. Farhan Abdullah, and I run Magnolia Functional Wellness in Southlake. We've hit the halfway point of the year, which is exactly when I sit down with my testosterone patients and pull up their full lab history. Not just today's results. All of them, side by side, going back to baseline. Because a man whose hematocrit reads 51 percent tells me one thing if it's been climbing steadily, and something completely different if it's been parked there since the day he started. Same number. Different conversation.

If you're on testosterone replacement therapy, the mid-year mark is the perfect time to stop looking at your labs as pass-fail and start reading them as a trend line. Let me walk you through how I actually do it.

Why a Single Lab Value Lies to You

Testosterone is not a steady-state hormone. It pulses. It dips in the afternoon, climbs overnight, and bounces around depending on your sleep, your stress, when you last injected, and whether you fasted before the draw. A total testosterone of 620 ng/dL on a Tuesday morning could easily read 740 the following week without you changing a thing. So when a man fixates on one decimal point, I gently remind him that he's chasing noise.

What doesn't lie is the pattern. If I see three consecutive trough levels of 450, 470, and 460, that's a stable, well-dosed patient even if none of those numbers is flashy. If I see 700, then 550, then 410, that downward drift tells me something's shifting long before he feels it. Maybe he's missing doses. Maybe his protocol needs adjusting. Maybe there's an absorption issue with his cream. The trend caught it. A single number never would have.

This is the mental shift I want every patient to make. Your labs aren't a report card you either pass or fail twice a year. They're a chart, and the slope of the line matters more than any one point on it. The 2018 Endocrine Society Clinical Practice Guideline by Bhasin and colleagues, published in the Journal of Clinical Endocrinology and Metabolism, makes this point in its own way: it recommends a standardized, repeated monitoring plan, not a one-and-done check. Repetition is the entire point. You can't spot a trend with a single data point.

The Numbers I Actually Track Over Time

When I review a patient's mid-year panel, I'm not staring at one line on the report. I'm watching a handful of markers move together, because they're all connected. Here's what earns my attention.

Total and free testosterone. Total tells me the headline. Free testosterone, the fraction actually available to your tissues, often tells me more, especially in men whose sex hormone-binding globulin runs high or low. I want to see both holding in a comfortable mid-normal range across draws, not spiking and crashing. A smooth line here usually means a man feels even, without the rollercoaster of energy and mood that comes from an erratic protocol.

Hematocrit and hemoglobin. This is the one I watch like a hawk. Testosterone stimulates red blood cell production, and in some men that drive pushes hematocrit too high, thickening the blood. A reading of 50 percent doesn't alarm me on its own. A reading of 50 percent that climbed from 44 over three draws absolutely gets my attention, because that slope predicts where we're heading. Catching the trend early lets me adjust the dose, change injection frequency, or recommend a blood donation before it becomes a real issue rather than a number on a screen.

PSA and prostate markers. Prostate-specific antigen isn't about a magic threshold so much as velocity, how fast it's moving. A stable PSA that ticks from 0.9 to 1.0 over a year is background noise. One that jumps from 1.1 to 2.4 in six months earns a conversation and likely a urology referral, regardless of whether it's still technically in range. Trends flag problems that absolute cutoffs miss.

Estradiol. Yes, men need estrogen, and testosterone converts into it. I track estradiol because too little leaves joints achy and libido flat, while too much can bring on moodiness and water retention. The sweet spot is individual, which is exactly why I care about your personal trend rather than a textbook range.

Metabolic and lipid markers. Fasting glucose, A1c, lipids, and sometimes a metabolic panel round things out. One of the quietly satisfying parts of this work is watching a man's triglycerides drift down and his insulin sensitivity improve as his body composition shifts over months on a well-run protocol. That story only shows up in the trend.

What a Healthy Trend Looks Like (and What a Red Flag Looks Like)

So what am I hoping to see at the six-month review? Honestly, something a little boring. Boring is good in lab medicine. I want testosterone holding steady in your optimal zone, hematocrit flat and well below the ceiling, PSA quiet, estradiol balanced, and your metabolic markers either stable or quietly improving. When the lines are calm and your symptoms have resolved, that's a protocol working exactly as designed. We don't fix what isn't broken.

Red flags are about direction and speed. A hematocrit creeping up draw after draw. A PSA accelerating. Testosterone levels that keep climbing past where we aimed, which usually means the dose is too high and needs to come down. Estradiol swinging wildly. None of these is necessarily an emergency in isolation, but each is a trajectory I'd rather interrupt early than discover late.

This is also where I push back on something I see in the online TRT world, where men chase ever-higher numbers thinking more is always better. It isn't. The goal of testosterone replacement therapy is to restore you to a healthy physiologic range and keep you there safely, not to redline your levels for a bigger number on a screen. The guidelines, and frankly my own years of watching these trends play out, point the same direction: stable and optimized beats high and volatile every single time.

The reassuring part is that the safety picture for properly monitored TRT has gotten clearer. The TRAVERSE trial, led by Lincoff and colleagues and published in the New England Journal of Medicine in 2023, followed thousands of middle-aged and older men with existing cardiovascular risk and found that testosterone therapy didn't raise their risk of heart attack or stroke compared to placebo. That doesn't mean we stop watching. It means that when we monitor the trends and keep your levels in a sensible range, the therapy holds up under serious scientific scrutiny.

How Often, and Why the Cadence Matters

The rhythm of monitoring isn't arbitrary. In the first year, I check labs more frequently, typically at baseline, around three months, and again at six to twelve months, because the early stretch is when your body is recalibrating and when trends are most likely to reveal something we need to act on. After things settle into a stable groove, at least annual labs become the floor, not the ceiling.

That annual minimum isn't just my preference. The 2024 review by Heidelbaugh and Belakovskiy in American Family Physician recommends measuring serum testosterone, hematocrit, and PSA at baseline and at least annually in men 40 and older on TRT. I tend to monitor a touch more closely than the minimum, especially in that first year, because more data points make for a clearer trend line. You can't see a slope with two dots as well as you can with five.

Here's the practical piece I'd ask of you. Try to standardize how you get drawn. Same lab when you can, similar time of day, similar interval from your last dose, fasting when we're tracking metabolic markers. Consistency in how you test makes the trend honest. If one draw is a fasted 7 a.m. trough and the next is a 4 p.m. peak after a big lunch, I'm comparing apples to oranges, and the line gets muddy. A little discipline on the front end makes the whole picture sharper.

I'll admit there's something almost seasonal about all this. We get a lot of men in here around now, half a year into a protocol they started as a New Year's resolution, finally feeling like themselves again just as the Texas summer hits and they want the energy to actually use it. Reviewing their trends at the midpoint is how we make sure the second half of the year keeps delivering what the first half started.

Bringing It All Together at Your Mid-Year Review

If you take one thing from this, let it be the reframe. Stop asking "is my number good?" and start asking "which way is my line moving?" That shift changes everything about how you and your physician make decisions. It turns lab work from a twice-a-year verdict into an ongoing conversation, one where we catch the small drifts before they become real problems and we leave the well-running protocols alone.

A proper mid-year review isn't just printing today's results and nodding. It's laying your whole history out, watching the markers move together, connecting what the trends show to how you actually feel, and adjusting only where the data tells us to. If you're new to all this and want the fuller picture of what monitoring on testosterone therapy involves, our TRT guide for men over 30 walks through it in plain language.

At Magnolia Functional Wellness in Southlake, this trend-based approach is simply how we practice. Your labs aren't a snapshot we glance at and forget. They're a story we read together, chapter by chapter, and the midpoint of the year is one of the best moments to turn the page and see where it's headed.

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX